University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.
It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.
AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE PREVIOUSLY ENROLLED IN THE ETROLIZUMAB PHASE III PROTOCOL GA29144View Trial
Molecular and Cellular Studies on Inflammation in Multiple SclerosisView Trial
NURTuRE – CKD
National Unified Renal Translational Research Enterprise – Chronic Kidney DiseaseView Trial
A randomized open label multicentre two-arm phase III comparative study assessing the role of mediastinal radiotherapy after rituximab containing chemotherapy regimens to patients with newly diagnosed Primary Mediastinal Large B-cell Lymphoma (PMLBCL)View Trial
CReST2 Colorectal Stenting Trial 2; Uncovered vs covered endoluminal stenting in the acute management of obstructing colorectal cancer in the palliative settingView Trial
Randomised trial of Selective bladder Preservation Against Radical Excision (cystectomy) in muscle invasive T2/T3 transitional cell carcinoma of the bladder feasibility studyView Trial
Early access to medicines scheme – nivolumab – for gastric and gastroesophageal junction (GC/GEJ) adenocarcinoma observational studyView Trial
A randomised Phase 2/3 trial of perioperative chemotherapy with or without Bevacizumab in operable adenocarcinoma of the stomach and gastro-oesophageal junctionView Trial
ENDCaP-C Test Accuracy Study
Enhanced Neoplasia Detection and Cancer Prevention in Chronic Colitis (ENDCaPC) A Multicentre test accuracy studyView Trial
A study assessing morbidity and portal circulation in patients with Myeloproliferative neoplasms and splanchnic vein thrombosisView Trial